Yüklüyor......
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Cystic fibrosis (CF) is a complex genetic disease characterized by death from loss of lung function. Therapies target pathophysiologic changes associated with pulmonary disease progression. Although therapeutic mechanisms differ, efficacy demonstration is limited to a few accepted outcome measures,...
Kaydedildi:
| Yayımlandı: | Clin Investig (Lond) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486293/ https://ncbi.nlm.nih.gov/pubmed/26146539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.11.174 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|